Semaglutide (brand names Ozempic, Wegovy, Rybelsus) and Tirzepatide (brand names Mounjaro, Zepbound) are injectable medications that help regulate blood sugar and reduce appetite by mimicking certain hormones involved in glucose regulation and digestion
Researchers can adjust dosing and duration based on the desired therapeutic effects, target area, severity of condition, and other factors
Please note that these compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality
However, in vitro potency does not predict clinical efficacy
Customer-Focused Pricing: C Qimo Biological Registration was established in 2023 and is affiliated with Kuxuan Biotechnology Co., Ltd